QuidelOrtho Corp — Form 8-K
Filed September 23, 2026 · analyzed by the 8-K Agent
8-K
▼ Likely negative
significance 72/100
What the filing says
QuidelOrtho Corporation executed Amendment No. 1 (dated September 23, 2026) to its credit agreement with Bank of America and other lenders. The amendment introduces a "Covenant Relief Period" (commencing Sept 23, 2026, ending on or before Oct 1, 2029) during which relaxed financial covenants apply: maximum Consolidated Leverage Ratio of 5.50x (declining to 4.25x by Sept 2029) and minimum Interest Coverage Ratio of 2.25x (rising to 3.00x by Sept 2029), versus standard levels of 4.50x and 3.00x respectively post-relief. The amendment restricts cash borrowings to $250M cap, limits acquisitions to $200M aggregate, caps restricted payments at $10M annually, and requires bank account control agreements. A 0.125% consent fee applies to lenders.
Why this rating
Covenant relief signals financial distress; relaxed leverage ratios (5.5x vs 4.5x) indicate operational strain. Meaningful relative to $1.9B market cap; ~3.7% of assets. Material restrictions on M&A, distributions, and liquidity signal lender caution.
Price action (we called it negative)
before filing · preread $10.34 | at our read pending | +10 min pending | +30 min pending | +1 hr pending | +4 hrs pending |
Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →
See more from September 23, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.